top of page

INTELLECTUAL

PROPERTY

Screenshot (214)_edited.jpg

Veresca™ FOXC1 IHC Breast Cancer Test and other Veresca™ products under development may be covered by one or more of the following United States patents; other U.S. patents and/or their international equivalents may also apply or be pending.  To the extent a name, product feature, design or logo does not appear on the following list, such omission does not constitute a waiver of any and all intellectual property rights that Onconostic Technologies, Inc. and 3N Diagnostic Ltd. have established in  any of its products, features, service names, product names or logos

Veresca™ FOXC1 IHC Breast Cancer Test and other Veresca™ products under development may be covered by one or more of the following United States patents; other U.S. patents and/or their international equivalents may also apply or be pending.  To the extent a name, product feature, design or logo does not appear on the following list, such omission does not constitute a waiver of any and all intellectual property rights that Onconostic Technologies, Inc. and 3N Diagnostics Ltd. have established in  any of its products, features, service names, product names or logos.

VERESCA BLUE WORDMARK_edited.png

VERESCA products are covered by one or more patents or pending patent applications worldwide.  See www.foxc1.info/patents 

           and VERESCA are trademarks owned by or licensed to the affiliated companies of 3N Diagnostics Ltd. and Onconostic Technologies, Inc.  ®  VERESCA is a registered trademark in the European Union and certain other countries throughout the world.  © 2020 The VERESCA Affiiates

3N Diagnostics Ltd.  Murray House, 1 Murray Street, Belfast Antrim BT1 6DN Northern Ireland, UK

bottom of page